Literature DB >> 23138260

Letter to the editor: Is there really no benefit of vertebroplasty for osteoporotic vertebral fractures? A meta-analysis.

David S Jevsevar, Stephen I Esses, Deborah S Cummins.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23138260      PMCID： PMC3549145          DOI： 10.1007/s11999-012-2667-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  10 in total

1.  Is there really no benefit of vertebroplasty for osteoporotic vertebral fractures? A meta-analysis.

Authors:  Ming-Min Shi; Xun-Zi Cai; Tiao Lin; Wei Wang; Shi-Gui Yan
Journal:  Clin Orthop Relat Res       Date:  2012-06-23       Impact factor: 4.176

2.  Comparing clinical outcomes following percutaneous vertebroplasty with conservative therapy for acute osteoporotic vertebral compression fractures.

Authors:  Hao-Kuang Wang; Kang Lu; Cheng-Loong Liang; Hui-Ching Weng; Kuo-Wei Wang; Yu-Duan Tsai; Ching-Hua Hsieh; Po-Chou Liliang
Journal:  Pain Med       Date:  2010-11       Impact factor: 3.750

3.  Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy.

Authors:  Terrence H Diamond; Bernard Champion; William A Clark
Journal:  Am J Med       Date:  2003-03       Impact factor: 4.965

4.  Percutaneous vertebroplasty: functional improvement in patients with osteoporotic compression fractures.

Authors:  Luis Alvarez; María Alcaraz; Antonio Pérez-Higueras; Juan J Granizo; Ignacio de Miguel; Roberto E Rossi; Diana Quiñones
Journal:  Spine (Phila Pa 1976)       Date:  2006-05-01       Impact factor: 3.468

5.  Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures.

Authors:  Majid Reza Farrokhi; Ehsanali Alibai; Zohre Maghami
Journal:  J Neurosurg Spine       Date:  2011-03-04

6.  Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial.

Authors:  Caroline A H Klazen; Paul N M Lohle; Jolanda de Vries; Frits H Jansen; Alexander V Tielbeek; Marion C Blonk; Alexander Venmans; Willem Jan J van Rooij; Marinus C Schoemaker; Job R Juttmann; Tjoen H Lo; Harald J J Verhaar; Yolanda van der Graaf; Kaspar J van Everdingen; Alex F Muller; Otto E H Elgersma; Dirk R Halkema; Hendrik Fransen; Xavier Janssens; Erik Buskens; Willem P Th M Mali
Journal:  Lancet       Date:  2010-08-09       Impact factor: 79.321

7.  Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema.

Authors:  M H J Voormolen; W J van Rooij; M Sluzewski; Y van der Graaf; L E H Lampmann; P N M Lohle; J R Juttmann
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

8.  A randomized trial of vertebroplasty for osteoporotic spinal fractures.

Authors:  David F Kallmes; Bryan A Comstock; Patrick J Heagerty; Judith A Turner; David J Wilson; Terry H Diamond; Richard Edwards; Leigh A Gray; Lydia Stout; Sara Owen; William Hollingworth; Basavaraj Ghdoke; Deborah J Annesley-Williams; Stuart H Ralston; Jeffrey G Jarvik
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

9.  A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.

Authors:  Rachelle Buchbinder; Richard H Osborne; Peter R Ebeling; John D Wark; Peter Mitchell; Chris Wriedt; Stephen Graves; Margaret P Staples; Bridie Murphy
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

10.  Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study.

Authors:  Rikke Rousing; Mikkel O Andersen; Stig M Jespersen; Karsten Thomsen; Jens Lauritsen
Journal:  Spine (Phila Pa 1976)       Date:  2009-06-01       Impact factor: 3.468
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.